Updated CIRSE Position Statement on the use of paclitaxel-coated balloons and stents in peripheral arterial disease

Dear IRSA members

IRSA would like to draw your attention to the following updated CIRSE press release regarding Paclitaxel coated and

eluting devices in the treatment of peripheral vascular disease. Further information can be found here.